phone icon (917) 310-3371 Explore MAT Treatment Menu
close menu
Nao Medical Logo

Telemedicine MAT treatment in NYC

Start with a virtual addiction medicine visit when clinically appropriate, then use local Nao Medical locations when in-person support is needed.

Telemedicine can make opioid use disorder treatment easier to start, but it still needs a careful medical review, prescription monitoring checks, pharmacy coordination, and a realistic follow-up plan.

Many major insurance plans are accepted for addiction medicine visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Self-pay visits are also available. Coverage for the visit, urine drug screening, and medication copays varies by plan, so benefit verification still matters.

Nao Medical clinic visit
Nao Medical clinic interior
Nao Medical patient care
Virtual access still needs real clinical structure A strong telemedicine MAT path tells patients when virtual care works, when in-person care is needed, and what happens after the first appointment.

What telemedicine MAT can cover

The first priority is safe, evidence-based treatment. Convenience matters, but it should never replace timing review, medication safety, and follow-up planning.

Online Suboxone evaluation

A telemedicine visit can review opioid use history, withdrawal timing, current medications, pharmacy access, safety, and whether buprenorphine treatment is appropriate.

Local follow-up if needed

In-person visits may be needed for clinical assessment, testing, medication administration, or when telemedicine rules do not fit the situation.

Medicaid and insurance review

The visit, testing, medication, and follow-up schedule should be checked against the patient's plan before care is finalized.

Safety planning

Telemedicine MAT should still include overdose-risk discussion, naloxone access, pharmacy coordination, and clear next steps if symptoms change.

Telemedicine rule context

SAMHSA describes a federal pathway that can allow buprenorphine initiation through phone or video telehealth under defined requirements and time limits. Patients can review the public Q&A; from SAMHSA.

MAT access by area

Related MAT options

Telemedicine MAT questions

Federal rules allow certain buprenorphine starts by audio-only or audio-visual telehealth when required checks are completed. Some situations still require in-person evaluation or a different authorized care pathway.
Telemedicine can be appropriate for some follow-up visits, especially when the patient is stable and the plan meets clinical, legal, and payer requirements.
Nao Medical locations in the Bronx, Brooklyn, Queens, Manhattan, and Long Island can support local follow-up when in-person care, testing, or medication administration is needed.
Insurance and Medicaid coverage may be available depending on the plan, visit type, state and federal rules, and clinical documentation requirements.

200,000+ 5-star reviews

What patients say about Nao Medical

Verified Patient
(4.9)

The visit was private, clear, and focused on what I needed to do next.

Verified Patient
(4.9)

They helped me understand medication timing and follow-up without making me feel judged.

Verified Patient
(4.9)

Insurance questions were handled before the plan moved forward.

Verified Patient
(4.9)

The team explained telemedicine and in-person follow-up in a way that made sense.

Verified Patient
(4.9)

I left with clearer next steps and a realistic appointment plan.

Verified Patient
(4.9)

The clinic made a difficult appointment feel organized and respectful.